Modified Hemoglobin Solution, with Desired Pharmacological Properties, Does not Activate Nuclear Transcription Factor NF-kappa B in Human Vascular Endothelial Cells

References

• Chang T MS. : Past, present and future perspectives on the 40th anniversary of hemoglobin based red blood cell substitutes. Artif Cells Blood Substit Immobil Biotechnol 1996; 24(4)ix–xxiv
   PubMedGoogle Scholar
• Winslow RM. : Blood substitutes - a moving target. Nature Med 1995; 1(11)1212–15
   PubMedGoogle Scholar
• Marwick C. : More than a trickle of interest in blood substitutes. JAMA 1994; 271: 895
   PubMedGoogle Scholar
• Hess J R, Macdonald V W, Gomez C S, Coppes V. Increased vascular resistance with hemoglobin-based oxygen carriers. Artif Cells Blood Substit Immobil Biotechnol 1994; 22: 361–72
   PubMed Web of Science ®Google Scholar
• Winslow RM. Hemoglobin-Based Red Cell Substitutes. The John Hopkins University Press, Baltimore 1992
   Google Scholar
• Simoni J, Feola M, Canizaro PC. Generation of free oxygen radicals and toxicity of hemoglobin solutions. Biomater Artif Cells Artif Organs 1990; 18: 189–202
   PubMed Web of Science ®Google Scholar
• Alayash AI. Hemoglobin-based blood substitutes: potential free radical toxicity. Free Rad Biol Med 1994; 16: 137–8
   PubMedGoogle Scholar
• Simoni J, Feola M, Tran R, Buckner M, Canizaro PC. Biocompatibility of hemoglobin solution. II. the inflammatory reaction of human monocytes and mouse peritoneal macrophages. Artif Organs 1990; 14: 98–109
   PubMedGoogle Scholar
• Simoni J, Simoni G, Lox C D, McGunegle D E, Feola M. Cytokines and PAF release from human monocytes and macrophages: effect of hemoglobin and contaminants. Artif Cells Blood Substit Immobil Biotechnol 1994; 22: 525–34
   PubMed Web of Science ®Google Scholar
• McFaul S J, Bowman P D, Villa V M, Gutierrez-Ibanez M J, Johnson M, Smith D. Hemoglobin stimulates mononuclear leukocytes to release interleukin-8 and tumor necrosis factor alpha. Blood 1994; 84: 3175–81
   PubMed Web of Science ®Google Scholar
• Smith D J, Winslow RM. Effects of extraerythrocytic hemoglobin and its components on mononuclear cell procoagulant activity. J Lab Clin Med 1992; 119: 176–82
   PubMed Web of Science ®Google Scholar
• Simoni J, Simoni G, Lox C D, Feola M. Reaction of human endothelial cells to bovine hemoglobin solution and tumor necrosis factor. Artif Cells Blood Substit Immobil Biotechnol 1994; 22: 777–87
   PubMed Web of Science ®Google Scholar
• Simoni J, Simoni G, Lox C D, Prien S D, Shires GT. Evidence for the direct inhibition of endothelin-1 secretion by hemoglobin in human endothelial cells. ASAIO Journal 1995; 31: M641–51
   Google Scholar
• Motterlini R, Foresti R, Vandegriff K, Intaglietta M, Winslow RM. Oxidative-stress response in vascular endothelial cells exposed to acellular hemoglobin solutions. Am J Physiol 1995; 269: H648–55
   PubMed Web of Science ®Google Scholar
• Alayash AI. Effects of intra- and intermolecular crosslinking on the free radical reactions of bovine hemoglobins. Free Rad Biol Med 1995; 18: 295–301
   PubMed Web of Science ®Google Scholar
• Alayash A I, Fratantoni J C, Bonaventura C, Bonaventura J, Bucci E. Consequences of chemical modification on the free radical reactions of human hemoglobin. Arch Biochem Biophys 1992; 298: 114–20
   PubMed Web of Science ®Google Scholar
• Cashon R E, Alayash AI. Reaction of human hemoglobin HbAo and two cross-linked derivatives with hydrogen peroxide: differential behavior of the ferryl intermediate. Arch Biochem Biophys 1995; 316: 461–69
   PubMed Web of Science ®Google Scholar
• Simoni J, Simoni G, Lox C D, Prien S D, Tran R, Shires GT. : Immunohistochemical evaluation of adhesion molecules and von Willebrand factor expression in human coronary artery endothelial cells incubated with different hemoglobin solutions. Artif Cells Blood Substit Immobil Biotechnol 1996; 24: 426
   Google Scholar
• Baeuerle P A, Baltimore PA. Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-kappa B transcription factor. Cell 1988; 53: 211–17
   PubMed Web of Science ®Google Scholar
• Grimm S, Baeuerle PA. The inducible transcription factor NF-kappa B: structure-function relationship of its protein subunits. Biochem J 1993; 290: 297–308
   PubMed Web of Science ®Google Scholar
• Collins T. Endothelial nuclear factor-kappa B and the initiation of the artheriosclerotic lesion. Lab Invest 1993; 68: 499–508
   PubMed Web of Science ®Google Scholar
• Parry G C, Mackman N. A set of inducible genes expressed by activated human monocytic and endothelial cells contain kappa B-like sites that specifically bind c-rel-p65 heterodimers. J Biol Chem 1994; 269: 20823–5
   PubMedGoogle Scholar
• Thanos D, Maniatis T. NF-kappa B: Lesson in family values. Cell 1995; 80: 529–32
   PubMed Web of Science ®Google Scholar
• Siebenlist U, Franzoso G, Brown K. Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol 1994; 10: 405–55
   PubMedGoogle Scholar
• Schreck R, Albermann K, Baeuerle PA. Nuclear factor kappa B: an oxidative stress responsive transcription factor of eukaryotic cells. Free Rad Res Commun 1992; 17: 221–37
   PubMed Web of Science ®Google Scholar
• Toledano M B, Leonard WJ. Modulation of transcription factor NF-kappa B binding activity by oxidationreduction in vitro. Proc Natl Acad Sci USA 1991; 88: 4328–32
   PubMed Web of Science ®Google Scholar
• Andreoli S P, Mallent C P, Bergstein JM. Role of glutathione in protecting endothelial cells against hydrogen peroxide oxidant injury. J Lab Clin Med 1986; 108: 190–8
   PubMed Web of Science ®Google Scholar
• Garcia-Ruiz C, Colell A, Morales A, Kaplowitz N, Fernandez-Checa JC. Role of oxidative stress generated from the mitochondrial electron transport chain and mitochondrial glutathione status in loss of mitochondrial function and activation of transcription factor nuclear factor-kappa B: studies with isolated mitochondria and rat hepatocytes. Mol Pharmacol 1995; 48: 825–34
   PubMed Web of Science ®Google Scholar
• Simoni J, Simoni G, Prien S D, Tran R M, Shires GT. : The intracellular antioxidant defense system status after massive transfusion of free Hb-based blood substitutes. ASAIO J 1995; 41: 3A
   Google Scholar
• Feola M, Simoni J, Canizaro PC. Polyhemoglobin Stabilized by Purin Derivatives and Glutathione. Australian Patent. No. 650 439, 1994
   Google Scholar
• Feola M, Simoni J, Canizaro PC. Blood Substitute. U.S. Patent. No. 5 439 882, 1995
   Google Scholar
• Feola M, Simoni J, Canizaro PC. Polyhemoglobin Stabilized with Purine Derivatives and Glutathione. European Patent. No. EP 0 507 870, 1996
   Google Scholar
• Simoni J, Simoni G, Feola M. Chromatographic analysis of biopolymers distribution in “polyhemoglobin”, an intermolecularly crosslinked hemoglobin solution. Anal Chim Acta 1993; 279: 73–88
   Google Scholar
• Feola M, Simoni J, Canizaro PC. Quality control of hemoglobin solutions: I. the purity of hemoglobin before modification. Artif Organs 1991; 15: 234–278
   Google Scholar
• Simoni J, Simoni G, Feola M, Canizaro PC. Evaluation of anion-exchange liquid chromatography for purification of hemoglobin from peptides and other proteins. Anal Chim Acta 1991; 249: 169–83
   Web of Science ®Google Scholar
• Winterbourn CC. Reactions of superoxide with hemoglobin. Handbook of Methods for Oxygen Radicals Research, RA Greenwald. CRC Press, Boca Raton, FL 1985; 137–41
   Google Scholar
• Simoni J, Simoni G, Lox C D, Prien S D, Shires GT. Hemoglobin interference with an enzyme-linked immunosorbent assay for detection of tumor necrosis factor-alpha. Anal Chim Acta 1995; 313: 1–14
   Google Scholar
• Yamada T, Volkmer C, Grisham MB. The effect of sulfasalazine metabolites on hemoglobin-catalyzed lipid peroxidation. J Free Radic Biol Med 1991; 10: 41–9
   Google Scholar
• Yagi K. : Assay for serum lipid peroxidase level and its clinical significance. Lipid Peroxidase in Biology and Medicine, H Yagi. Academic Press, New York 1982; 223–42
   Google Scholar
• Beutler D, Duron O, Kelly B. Improved method for the determination of blood glutathione. J Lab Clin Med 1963; 61: 882–5
   PubMed Web of Science ®Google Scholar
• Singh S, Aggarwal BB. Activation of transcription factor NF-kappa B is suppressed by curcumin (Diferulolylmethane). J. Biol Chem 1995; 270: 24995–5000
   PubMed Web of Science ®Google Scholar
• Ramanujam P, Fogerty S, Heiser W, Jolly J. Fast gel electrophoresis to analyze DNA-protein interactions. Bio Techniques 1990; 8: 556–63
   PubMedGoogle Scholar
• Simoni J, Simoni G, Lox C D, Prien S D, Tran R, Shires GT. Expression of adhesion molecules and von Willebrand factor in human coronary artery endothelial cells incubated with differently modified hemoglobin solutions. Artif Cells Blood Substit Immobil Biotechnol, in press
   Google Scholar
• Sen C K, Roy S, Packer L. Involvement of intracellular Ca2+ in oxidant-induced NF-kappa B activation. FEBS Lett 1996; 385: 58–62
   PubMed Web of Science ®Google Scholar
• Verma I M, Stevenson J K, Schwartz E M, Van Antwerp D, Miyamato S. Rel/NF-kappa B/I kappa B family; intimate tales of association and dissociation. Genes & Development 1995; 9: 2723–35
   PubMed Web of Science ®Google Scholar
• Read M A, Whitley M Z, Williams A J, Collins T. NF-kappa B and I kappa B alpha: an inducible regulatory system in endothelial activation. J Exp Med 1994; 179: 503–12
   PubMed Web of Science ®Google Scholar
• Pahl H L, Baeuerle PA. Oxygen and the control of gene expression. BioEssays 1994; 16: 497–502
   PubMed Web of Science ®Google Scholar
• Anadalibi A, Liao F, Imes S, Fogelman A M, Lusis AJ. Oxidized lipoproteins influence gene expression by causing oxidative stress and activating the transcription factor NF-kappa B. Biochem Soc Trans 1993; 21: 651–5
   PubMedGoogle Scholar
• Henning B, Toborek M, Joshi-Barve S, Barger S W, Barve S, Mattson M P, McClain CJ. Linoleic acid activates nuclear transcription factor-kappa B (NF-kappa B) and induces NF-kappa B-dependent transcription in cultured endothelial cells. Am J Clin Nutr 1996; 63: 322–8
   PubMedGoogle Scholar
• Yoshida Y, Kashiba K, Niki E. Free radical mediated oxidation of lipids induced by hemoglobin in aqueous dispersions. Biochim Biophys Acta 1994; 1201: 165–72
   PubMed Web of Science ®Google Scholar
• Simoni J, Simoni G, Garcia E L, Prien S D, Tran R, Feola M, Shires GT. Protective effect of selenium on hemoglobin mediated lipid peroxidation in. vivo. Artif Cells Blood Substit Immobil Biotechnol 1995; 23: 469–86
   PubMed Web of Science ®Google Scholar
• Zang H, Weir B KA, Macdonald L, Marton L S, Solenski N J, Kwan A-L, Lee KS. Mechanism of [Ca++li elevation induced by erythrocyte components in endothelial cells. J Phramacol Exp Ther 1996; 277: 1501–9
   PubMedGoogle Scholar
• McFaul S J, Bowman P D, Ibanez M G, Holt P. : The effects of purified hemoglobin solutions on leukocytes and endothelial cells. Biomater Artif Cells Artif Organs 1991; 19: 436
   Google Scholar
• Simoni J, Simoni G, Newman G, Hartsell A, Feola M. : A novel free Hb-based blood substitute. In vivo evaluation of its cardiovascular and renal effects. Artif Cells Blood Substit Immobil Biotechnol 1996; 24: 427
   Google Scholar
• Feola M, Simoni J, Angelillo R, Luhruma Z, Kabakele M, Manzobi M, Kaluila M. Clinical trial of a hemoglobin based blood substitute in patients with sickle cell anemia. Surg Gynecol Obstet 1992; 174: 379–86
   PubMedGoogle Scholar
• Simoni J, Simoni G, Newman G, Feola M. An improved blood substitute: In vivo evaluation of its hemodynamic effects. ASAIO Journal 1996; 42: M773–M782
   PubMedGoogle Scholar
• Enger RL. Adenosine. The signal of life. Circulation 1991; 84: 951–4
   PubMedGoogle Scholar
• Hayens J, Jr., Obuako B, Thompson W J, Downey J. Adenosine induced vasodilation: receptor characterization in pulmonary circulation. Am J Physiol 1995; 268: H1862–8
   PubMedGoogle Scholar
• Daval J L, Nehling A, Nicolas F. Physiological and pharmacological properties of adenosine: therapeutic implications. Life Sci 1991; 49: 1435–53
   PubMedGoogle Scholar
• Yamagishi T, Yaginisawa T, Satoh K, Taira N. Relaxant mechanism of cyclic AMP-increasing agents in porcine coronary artery. Eur J Pharmacol 1994; 251: 253–62
   PubMedGoogle Scholar
• Silver P J, Walus K, DiSalvo J. Adenosine-mediated relaxation and activation of cyclic AMP-dependent protein kinase in coronary arterial smooth muscle. J Pharmacol Exper Therap 1984; 228: 342–7
   PubMed Web of Science ®Google Scholar
• Matsunaga T, Okumura K, Tsunoda R, Tayama S, Tabuchi K, Yasue H. Role of adenosine in regulation of coronary flow in dogs with inhibited synthesis of endothelium-derived nitric oxide. Am J Physiol 1996; 270: H427–34
   PubMedGoogle Scholar
• Cronstein BN. Adenosine, an endogenous and-inflammatory agent. J Appl Physiol 1994; 76: 5–13
   PubMed Web of Science ®Google Scholar
• Maggirwar S B, Dhanraj D N, Somani S M, Ramkumar V. Adenosine acts as an endogenous activator of the cellular antioxidant defense system. Biochem Biophys Res Commun 1994; 201: 508–15
   PubMed Web of Science ®Google Scholar
• Bouma M G, Stad R K, Van der Wildenberg F AJM, Buurman WA. Differential regulatory effects of adenosine on cytokine release by activated human monocytes. J Immunol 1994; 153: 4159–68
   PubMed Web of Science ®Google Scholar
• Bouma M G, Van der Wildenberg F AJM, Buurman WA. Adenosine inhibits cytokine release and expression of adhesion molecules by activated human endothelial cells. Am J Physiol 1996; 270: C522–9
   PubMedGoogle Scholar
• Adkins W K, Barnard J W, May S, Siebert A F, Haynes J, Taylor AE. Compounds that increase cAMP prevent ischemia-reperfusion pulmonary capilary injury. J Appl Physiol 1992; 72: 492–7
   PubMed Web of Science ®Google Scholar
• Morandini R, Ghanem G, Portier-Lemarie A, Robaye B, Renaud A, Boeynaems JM. Action of cAMP on expression and release of adhesion molecules in human endothelial cells. Am J Physiol 1996; 270: H807–16
   PubMedGoogle Scholar
• Ghersa P, Van Huijsduijnen R H, Whelan J, Cambert Y, Pescini R, DeLamarter JF. Inhibition of E-selectin gene transcription through a cAMP-dependent protein kinase pathway. J Biol Chem 1994; 269: 29129–37
   PubMedGoogle Scholar
• Lincoln T M, Comwell T L, Taylor AE. cAMP-dependent protein kinase mediated the reduction of Ca2+ by cAMP in vascular smooth muscle cells. Am J Physiol 1990; 258: C300–407
   Google Scholar
• Jans DA. The regulation of protein transport to the nucleus by phosphorylation. Biochem J 1995; 311: 705–16
   PubMedGoogle Scholar
• Ramkumar V, Nie Z, Rybak L P, Maggirwar SB. Adenosine, antioxidant enzymes and cytoprotection. TlPS 1995; 16: 283–5
   Google Scholar